Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - November 2002

  1. Pneumococcal Vaccination for Cochlear Implant Recipients.  MMWR Morb.Mortal.Wkly.Rep.  10-18-2002, 51 (41): 931.

  2. Vaccination Mondiale Et Terreur Mondiale.  CMAJ.  10-15-2002, 167 (8): 839.

  3. Global Vaccination Meets Global Terror.  CMAJ.  10-15-2002, 167 (8): 837, 839.

  4. From the Centers for Disease Control and Prevention. National, State, and Urban Area Vaccination Levels Among Children Aged 19-35 Months--United States, 2001.  JAMA  10-9-2002, 288 (14): 1713-1714.

  5. VI.7 Vaccine Recommendations for Patients on Chronic HD (Except HB Vaccination).  Nephrol.Dial.Transplant.  2002, 17 Suppl 7:81-87.

  6. Progress in Polio Eradication: Vaccine Strategies for the End Game. Paris, France, 28-30 June 2000. Proceedings.  Dev.Biol.(Basel)  2001, 105:1-244.

  7. Hazards of Immunisation.  Lancet  10-21-1967, 2 (7521): 888-889.

  8. Abbey, D. M.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1717.

  9. Ahmed, F., Elbasha, E. E., Thompson, B. L., Harris, J. R., and Sneller, V. P.  Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination.  Med.Decis.Making  2002, 22 (5 Suppl): S58-S66. 

  10. Arita, I.  Duration of Immunity After Smallpox Vaccination: A Study on Vaccination Policy Against Smallpox Bioterrorism in Japan.  Jpn.J Infect.Dis.  2002, 55 (4): 112-116.

  11. Batayneh, N. and Bdour, S.  Mumps: Immune Status of Adults and Epidemiology As a Necessary Background for Choice of Vaccination Strategy in Jordan.  APMIS  2002, 110 (7-8): 528-534.

  12. Birchmeier, M., Favrat, B., Pecoud, A., Abetel, G., Karly, M., Landry, P., Mancini, M., Verdon, F., and Genton, B.  Improving Influenza Vaccination Rates in the Elderly.  J Fam.Pract.  2002, 51 (10): 856. 

  13. Borrow, R., Goldblatt, D., Andrews, N., Southern, J., Ashton, L., Deane, S., Morris, R., Cartwright, K., and Miller, E.  Antibody Persistence and Immunological Memory at Age 4 Years After Meningococcal Group C Conjugate Vaccination in Children in the United Kingdom.  J Infect.Dis.  11-1-2002, 186 (9): 1353-1357. 

  14. Bunout, D., Hirsch, S., Pia, de la Maza, Munoz, C., Haschke, F., Steenhout, P., Klassen, P., Barrera, G., Gattas, V., and Petermann, M.  Effects of Prebiotics on the Immune Response to Vaccination in the Elderly.  JPEN J Parenter.Enteral Nutr.  2002, 26 (6): 372-376. 

  15. Charatan, F.  US Health Officials Recommend Offering Smallpox Vaccination to All.  BMJ  10-12-2002, 325 (7368): 794.

  16. Davies, P.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1717.

  17. Graham-Rowe, D. and MacKenzie, D.  Tough Choices: Would a Separate Measles Vaccination Be a Disaster for Britain?.  New Sci.  2-16-2002, 173 (2330): 12-13.

  18. Greene, A.  Vaccination Fears: What the School Nurse Can Do.  J Sch Nurs.  2002, Suppl:31-5. (): 31-35.

  19. Gurfinkel, E. and Mautner, B.  Secondary Prevention of Coronary Artery Disease. Flu Vaccinations and New Evidence of the Role of Infection in Acute Coronary Syndromes.  Rev.Esp.Cardiol.  2002, 55 (10): 1009-1012. 

  20. Hasanain, F. H. and Jan, M. M.  Delays in Primary Vaccination of Infants Living in Western Saudi Arabia.  Saudi.Med.J  2002, 23 (9): 1087-1089.

  21. Jonsson, S., Vidarsson, G., Valdimarsson, H., Schiffman, G., Schneerson, R., and Jonsdottir, I.  Vaccination of COPD Patients With a Pneumococcus Type 6B Tetanus Toxoid Conjugate Vaccine.  Eur.Respir.J  2002, 20 (4): 813-818.
     
  22. Levitsky, J., Te, H. S., Faust, T. W., and Cohen, S. M.  Varicella Infection Following Varicella Vaccination in a Liver Transplant Recipient.  Am.J Transplant.  2002, 2 (9): 880-882. 

  23. Makela, A., Nuorti, J. P., and Peltola, H.  Neurologic Disorders After Measles-Mumps-Rubella Vaccination.  Pediatrics  2002, 110 (5): 957-963. 

  24. Manuel, D. G., Henry, B., Hockin, J., and Naus, M.  Health Behavior Associated With Influenza Vaccination Among Healthcare Workers in Long-Term-Care Facilities.  Infect.Control Hosp.Epidemiol.  2002, 23 (10): 609-614.

  25. Mayor, S.  Chief Medical Officer Confirms Key Health Workers Will Be Vaccinated Against Smallpox.  BMJ  2002, 19; 325 (7369): 855B.

  26. Rangel, M. C., Schoenbach, V., Hogan, V., and Weigle, K.  #72-S Racial/Ethnic Disparities in Influenza Vaccination in Elderly Adults. The Role of Access to Care.  Ann.Epidemiol.  2002, 12 (7): 516. 

  27. Mostowy, S. and Behr, M. A.  Comparative Genomics in the Fight Against Tuberculosis: Diagnostics, Epidemiology, and BCG Vaccination.  Am.J Pharmacogenomics.  2002, 2 (3): 189-196. 

  28. Nakatani, H., Sano, T., and Iuchi, T.  Development of Vaccination Policy in Japan: Current Issues and Policy Directions.  Jpn.J Infect.Dis.  2002, 55 (4): 101-111. 

  29. Nasir, L.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1718.

  30. Neff, J. M., Lane, J. M., Fulginiti, V. A., and Henderson, D. A.  Contact Vaccinia--Transmission of Vaccinia From Smallpox Vaccination.  JAMA  10-16-2002, 288 (15): 1901-1905.

  31. Ogunbanjo, G. A., Durrheim, D. N., Gouws, A., and Grobler, S.  Intradermal BCG Vaccination--Limiting Local Adverse Reactions.  S Afr.Med.J  2002, 92 (9): 665-666.

  32. Pasinetti, G. M., Ho, L., and Pompl, P.  AN1792 Vaccination Immunotherapy in Alzheimer's Disease: the Case of a Therapy Before Its Time.  Neurobiol.Aging  2002, 23 (5): 683.

  33. Plans, P.  [Cost-Effectiveness of 23-Valent Antipneumococcical Vaccination in Catalonia, Spain].  Gac.Sanit.  2002, 16 (5): 392-400. 

  34. Portaels, F., Aguiar, J., Debacker, M., Steunou, C., Zinsou, C., Guedenon, A., and Meyers, W. M.  Prophylactic Effect of Mycobacterium Bovis BCG Vaccination Against Osteomyelitis in Children With Mycobacterium Ulcerans Disease (Buruli Ulcer).  Clin.Diagn.Lab Immunol.  2002, 9 (6): 1389-1391. 

  35. Rush, C., Mitchell, T., and Garside, P.  Efficient Priming of CD4(+) and CD8(+) T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways.  J Immunol.  11-1-2002, 169 (9): 4951-4960. 

  36. Schlafly, R.  Antivaccination Web Sites.  JAMA  10-9-2002, 288 (14): 1717.

  37. Sibley, C. L.  Smallpox Vaccination Revisited.  Am.J Nurs.  2002, 102 (9): 26-32. 

  38. Steiner, M., Vermeulen, L. C., Mullahy, J., and Hayney, M. S.  Factors Influencing Decisions Regarding Influenza Vaccination and Treatment: a Survey of Healthcare Workers.  Infect.Control Hosp.Epidemiol.  2002, 23 (10): 625-627. 

  39. Tan, H. H. and Seow, C. S.  A Review of Cutaneous Granulomas and Lupus Vulgaris Following BCG Vaccination in a Skin Hospital in Singapore.  Ann.Acad.Med.Singapore  2002, 31 (5): 663-665. 

  40. Tarjan, P., Sipka, S., Marodi, L., Nemes, E., Lakos, G., Gyimesi, E., Kiss, E., Ujj, G., and Szegedi, G.  No Short-Term Immunological Effects of Pneumococcus Vaccination in Patients With Systemic Lupus Erythematosus.  Scand.J Rheumatol.  2002, 31 (4): 211-215. 

  41. Tom, B., Moutou, F., Dufour, B., and Durand, B.  Ring Vaccination Against Foot-and-Mouth Disease.  Comp Immunol.Microbiol.Infect.Dis.  2002, 25 (5-6): 365-372. 

  42. Wang, L., Smith, D., Bot, S., Dellamary, L., Bloom, A., and Bot, A.  Noncoding RNA Danger Motifs Bridge Innate and Adaptive Immunity and Are Potent Adjuvants for Vaccination.  J Clin.Invest  2002, 110 (8): 1175-1184. 

  43. Weightman, G. W.  Scientific Evidence Supports Anthrax Vaccination.  Am.J Public Health  2002, 92 (11): 1707-1708.

  44. Wutzler, P., Neiss, A., Banz, K., Goertz, A., and Bisanz, H.  Can Varicella Be Eliminated by Vaccination? Potential Clinical and Economic Effects of Universal Childhood Varicella Immunisation in Germany.  Med.Microbiol.Immunol.(Berl)  2002, 191 (2): 89-96. 

Back to Top